PEN
Penumbra Inc
$318.31
+0.08 (+0.03%)
At close · Jul 7
Market Cap
$12.52B
Shares
39,331,425
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$1.4B
+17.5%
FY2025
Net Income
$177.69M
+1168.1%
FY2025
Gross Margin
67.14%
+3.9pp
FY2025
Operating Margin
13.48%
+12.7pp
FY2025
Diluted EPS
$4.52
+1155.6%
FY2025
Operating Cash Flow
$238.66M
+41.7%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $1.45B | $1.4B | $1.19B | $1.06B | $847.13M | $747.59M | $560.41M | $547.41M | $444.94M | $333.76M | $263.32M | $186.1M | $125.51M | $88.85M | |
| $474.32M | $461.23M | $439.62M | $375.88M | $311.93M | $272.21M | $222.24M | $175.44M | $152.41M | $116.62M | $92.49M | $62.04M | $42.67M | $30.97M | |
| $979.97M | $942.44M | $755M | $682.64M | $535.21M | $475.38M | $338.18M | $371.96M | $292.53M | $217.14M | $170.83M | $124.06M | $82.84M | $57.88M | |
| — | 67.14% | 63.2% | 64.49% | 63.18% | 63.59% | 60.34% | 67.95% | 65.75% | 65.06% | 64.88% | 66.66% | 66% | 65.14% | |
| $90.07M | $89.77M | $94.78M | $84.42M | $79.41M | $104.55M | $90.05M | $51.72M | $36.17M | $31.66M | $23.88M | $18.03M | $15.58M | $14.08M | |
| $702.76M | $663.42M | $573.99M | $506.45M | $449.72M | $378.33M | $287.07M | $272.73M | $226.39M | $184.32M | $148.3M | $101.85M | $64.26M | $44.92M | |
| $724K | $712K | $5.45M | $10.21M | $9.18M | $2.88M | $1.07M | $1.05M | $1.1M | $418K | $0 | $0 | — | — | |
| — | $17.47M | $23.7M | $27.26M | $24.32M | $16.41M | $12.89M | $8.1M | $6.17M | $3.78M | $2.3M | $1.75M | $751K | $677K | |
| — | — | $4.97M | — | — | — | — | — | — | — | — | — | — | — | |
| $792.83M | $753.19M | $745.72M | $609.09M | $529.13M | $482.88M | $377.12M | $324.46M | $293.39M | $215.98M | $172.18M | $119.88M | $79.83M | $59M | |
| $187.13M | $189.25M | $9.28M | $73.55M | $6.08M | -$7.5M | -$38.94M | $47.51M | -$852K | $1.17M | -$1.35M | $4.18M | $3.01M | -$1.13M | |
| — | 13.48% | 0.78% | 6.95% | 0.72% | -1% | -6.95% | 8.68% | -0.19% | 0.35% | -0.51% | 2.25% | 2.4% | -1.27% | |
| — | $206.72M | $32.98M | $100.81M | $30.4M | $8.91M | -$26.05M | $55.61M | $5.32M | $4.95M | $947K | $5.93M | $3.76M | -$449K | |
| $1.31M | $1.31M | $1.42M | $1.74M | $1.75M | $1.93M | — | — | — | — | — | — | — | — | |
| $17.78M | $16.29M | $13.69M | $6.83M | $1.89M | $2.87M | — | — | — | — | — | — | — | — | |
| $15.82M | $15.88M | $11.59M | $6.1M | -$2.19M | -$3M | -$343K | -$227K | -$504K | -$1.34M | -$1.84M | -$696K | -$309K | -$474K | |
| — | — | — | — | — | — | $0 | $0 | -$3.1M | -$1.43M | $0 | $0 | — | — | |
| $202.96M | $205.13M | $20.87M | $79.65M | $3.89M | -$10.5M | -$38.02M | $50.14M | $1.61M | $2.48M | -$869K | $4.02M | $3.14M | -$1.26M | |
| $31.91M | $27.44M | $6.86M | -$11.3M | $5.89M | -$13.13M | -$18.76M | $3.13M | -$4.4M | -$3.61M | -$15.68M | $1.66M | $894K | -$5.35M | |
| $171.05M | $177.69M | $14.01M | $90.95M | -$2M | $5.28M | -$15.7M | $48.46M | $6.6M | $4.66M | $14.81M | $2.37M | $2.25M | $4.1M | |
| — | 12.66% | 1.17% | 8.59% | -0.24% | 0.71% | -2.8% | 8.85% | 1.48% | 1.4% | 5.63% | 1.27% | 1.79% | 4.61% | |
| — | — | — | $0 | $0 | -$2.66M | -$3.56M | -$1.45M | -$3.69M | $0 | $0 | — | — | — | |
| $28.19M | — | — | — | — | — | — | — | — | $4.66M | $14.81M | $1.08M | -$833K | $887K | |
| $176.25M | $187.88M | $11.32M | $95.93M | -$7.5M | $113K | -$10.84M | $48.08M | $3.09M | $10.91M | $12.24M | $1.11M | $585K | $3.49M | |
| USD/shares | — | $4.57 | $0.36 | $2.37 | -$0.05 | $0.14 | -$0.44 | $1.39 | $0.19 | $0.14 | $0.49 | $0.09 | -$0.18 | $0.21 |
| USD/shares | — | $4.52 | $0.36 | $2.32 | -$0.05 | $0.14 | -$0.44 | $1.34 | $0.18 | $0.13 | $0.44 | $0.08 | -$0.18 | $0.14 |
| shares | — | 38.92M | 38.63M | 38.4M | 37.84M | 36.76M | 35.77M | 34.75M | 34.14M | 32.98M | 30.46M | 11.99M | 4.61M | 4.3M |
| shares | — | 39.29M | 39.27M | 39.22M | 37.84M | 37.88M | 35.77M | 36.27M | 36.09M | 35.32M | 33.48M | 14.22M | 4.61M | 6.5M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2025: $100.39M in buybacks.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Medical Devices median 3.70×
EV/EBIT
—
Medical Devices median 21.44×
P/E (TTM)
73.34×
Medical Devices median 26.54×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Geography (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|
| United States | $1,091,761,000 | $902,067,000 | $757,151,000 | $591,715,000 | $527,789,000 | $400,270,000 | $355,222,000 | $290,716,000 |
| Non Us | $311,904,000 | $292,548,000 | $301,371,000 | $255,418,000 | $219,801,000 | $160,142,000 | $192,183,000 | $154,222,000 |
By Product & Service (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|
| Thrombectomy | $947,918,000 | $815,475,000 | $677,343,000 | $511,137,000 | $437,775,000 | — | — | — |
| Embolization | $455,747,000 | $379,140,000 | $381,179,000 | $335,996,000 | $309,815,000 | — | — | — |
| Neuro | — | — | — | — | — | $292,629,000 | $331,685,000 | $294,333,000 |
| Peripheral Vascular | — | — | — | — | — | $267,783,000 | $215,720,000 | $150,605,000 |